| Product Code: ETC12626223 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Oncology Anti-Cancer Drugs Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Oncology Anti-Cancer Drugs Market - Industry Life Cycle |
3.4 Thailand Oncology Anti-Cancer Drugs Market - Porter's Five Forces |
3.5 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.9 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Oncology Anti-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in Thailand |
4.2.2 Growing awareness about cancer treatment options |
4.2.3 Technological advancements in oncology drugs |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for anti-cancer drugs |
4.3.2 High cost associated with oncology drugs |
4.3.3 Limited access to advanced cancer treatments in certain regions of Thailand |
5 Thailand Oncology Anti-Cancer Drugs Market Trends |
6 Thailand Oncology Anti-Cancer Drugs Market, By Types |
6.1 Thailand Oncology Anti-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.4 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.5 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.1.6 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.1.7 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Precision Medicine, 2021 - 2031F |
6.2 Thailand Oncology Anti-Cancer Drugs Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021 - 2031F |
6.2.5 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.6 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Leukemia, 2021 - 2031F |
6.3 Thailand Oncology Anti-Cancer Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.4 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.3.5 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Topical, 2021 - 2031F |
6.3.6 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4 Thailand Oncology Anti-Cancer Drugs Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.4.3 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.4.4 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.4.5 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.4.6 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5 Thailand Oncology Anti-Cancer Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5.4 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.5 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.5.6 Thailand Oncology Anti-Cancer Drugs Market Revenues & Volume, By Mail Order Pharmacies, 2021 - 2031F |
7 Thailand Oncology Anti-Cancer Drugs Market Import-Export Trade Statistics |
7.1 Thailand Oncology Anti-Cancer Drugs Market Export to Major Countries |
7.2 Thailand Oncology Anti-Cancer Drugs Market Imports from Major Countries |
8 Thailand Oncology Anti-Cancer Drugs Market Key Performance Indicators |
8.1 Number of new cancer cases diagnosed annually in Thailand |
8.2 Percentage of cancer patients opting for oncology drugs as part of their treatment |
8.3 Adoption rate of innovative oncology drugs in Thailand |
9 Thailand Oncology Anti-Cancer Drugs Market - Opportunity Assessment |
9.1 Thailand Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Thailand Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Thailand Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Thailand Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.5 Thailand Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Oncology Anti-Cancer Drugs Market - Competitive Landscape |
10.1 Thailand Oncology Anti-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 Thailand Oncology Anti-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here